59.21 USD
▼-0.33-0.55%
盘后 60.26 0.00%
2026-09-15
市值
$8.81B
市盈率
—
EPS
-7.65
股息率
—
52 周区间
30.81 – 65.00
成交量
1.89M
Beta
1.22
目标价
109.00
52W 低 30.8152W 高 65.00
价格走势
公司简介
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused b...